Literature DB >> 24966492

A case of severe ovarian hyperstimulation syndrome.

Moushumi Lodh1, Jheelam Mukhopadhyay2, Vikas Sharma3.   

Abstract

Ovulation induction has been an important mode of treatment of infertility. Ovarian stimulation may result in a supraphysiologic response leading to an iatrogenic complication known as the ovarian hyperstimulation syndrome (OHSS). This syndrome is potentially a lethal condition, the pathophysiologic hallmark of which is the accumulation of massive extravascular exudate combined with profound intravascular volume depletion and hemoconcentration. We report a case of severe OHSS with very large ovaries in a 35 year old case of embryo transfer. The patient presented to the emergency department with abdominal pain, massive ascites, respiratory distress and amenorrhea. The patient was managed symptomatically with no complications. Although ovarian hyperstimulation is a rare entity, it is important that the physician recognizes this condition. Prompt diagnosis and successful management is likely to avoid serious and rapid development of complications.

Entities:  

Keywords:  Anti cardiolipin antibodies; Assisted reproduction; Gonadotropin; Ovarian hyperstimulation syndrome; Ovarian stimulation; Ovulation induction

Year:  2013        PMID: 24966492      PMCID: PMC4062660          DOI: 10.1007/s12291-013-0390-4

Source DB:  PubMed          Journal:  Indian J Clin Biochem        ISSN: 0970-1915


  10 in total

Review 1.  The pathophysiology of ovarian hyperstimulation syndrome--views and ideas.

Authors:  U Elchalal; J G Schenker
Journal:  Hum Reprod       Date:  1997-06       Impact factor: 6.918

Review 2.  Ovarian hyperstimulation syndrome: pathophysiology and prevention.

Authors:  Carolina O Nastri; Rui A Ferriani; Isa A Rocha; Wellington P Martins
Journal:  J Assist Reprod Genet       Date:  2010-02-06       Impact factor: 3.412

3.  Severe unilateral hydrothorax as the only manifestation of the ovarian hyperstimulation syndrome.

Authors:  D Rabinerson; J Shalev; M Royburt; Z Ben-Rafael; A Dekel
Journal:  Gynecol Obstet Invest       Date:  2000       Impact factor: 2.031

4.  Autoimmune thyroid disease and antiphospholipid antibodies.

Authors:  D Nabriski; M Ellis; R Ness-Abramof; M Shapiro; L Shenkman
Journal:  Am J Hematol       Date:  2000-05       Impact factor: 10.047

Review 5.  The pathophysiology of ovarian hyperstimulation syndrome: an unrecognized compartment syndrome.

Authors:  Lisa C Grossman; Konstantinos G Michalakis; Hyacinth Browne; Mark D Payson; James H Segars
Journal:  Fertil Steril       Date:  2010-09       Impact factor: 7.329

6.  Ovarian hyperstimulation syndrome: current views on pathophysiology, risk factors, prevention, and management.

Authors:  Michael M Alper; Laura P Smith; Eric Scott Sills
Journal:  J Exp Clin Assist Reprod       Date:  2009-06-10

7.  Value of the serum estradiol level for preventing ovarian hyperstimulation syndrome: a retrospective case control study.

Authors:  Arianna D'Angelo; Rachel Davies; Emad Salah; Barry A Nix; Nazar N Amso
Journal:  Fertil Steril       Date:  2004-02       Impact factor: 7.329

Review 8.  Predicting and preventing ovarian hyperstimulation syndrome (OHSS): the need for individualized not standardized treatment.

Authors:  Klaus Fiedler; Diego Ezcurra
Journal:  Reprod Biol Endocrinol       Date:  2012-04-24       Impact factor: 5.211

9.  New algorithm for OHSS prevention.

Authors:  Evangelos G Papanikolaou; Peter Humaidan; Nikos Polyzos; Sofia Kalantaridou; Sahar Kol; Claudio Benadiva; Herman Tournaye; Basil Tarlatzis
Journal:  Reprod Biol Endocrinol       Date:  2011-11-03       Impact factor: 5.211

10.  Comparison of assisted reproductive technology outcomes in infertile women with polycystic ovary syndrome: In vitro maturation, GnRH agonist, and GnRH antagonist cycles.

Authors:  Min Hye Choi; Sun Hee Lee; Hye Ok Kim; Sun Hwa Cha; Jin Young Kim; Kwang Moon Yang; In Ok Song; Mi Kyoung Koong; Inn Soo Kang; Chan Woo Park
Journal:  Clin Exp Reprod Med       Date:  2012-12-31
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.